Loading…
Sabra Health Care REIT, Inc. is projected to rise to $24.40 by 2027, a +19% move from its current price of $20.45. SBRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $20.25 | $20.45 | $20.65 | -0.01% |
| May 30 | $20.17 | $20.45 | $20.73 | -0.02% |
| May 31 | $20.10 | $20.45 | $20.79 | -0.02% |
| Jun 1 | $20.05 | $20.44 | $20.85 | -0.03% |
| Jun 2 | $20.00 | $20.44 | $20.89 | -0.04% |
| Jun 3 | $19.96 | $20.44 | $20.93 | -0.05% |
| Jun 4 | $19.92 | $20.44 | $20.97 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $19.92 | $20.44 | $20.97 | -0.06% |
| Week 2 | $19.70 | $20.43 | $21.19 | -0.11% |
| Week 3 | $19.52 | $20.42 | $21.35 | -0.17% |
| Week 4 | $19.38 | $20.40 | $21.48 | -0.22% |
| Week 5 | $19.25 | $20.39 | $21.60 | -0.28% |
| Week 6 | $19.13 | $20.38 | $21.71 | -0.34% |
| Week 7 | $19.03 | $20.37 | $21.81 | -0.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Sabra Health Care REIT, Inc. trades under the symbol SBRA and is currently priced at $20.72.
The company has a market cap of $5.23B and is ranked 1313.
Forecasts show a path of value appreciation, with the 2026 average price forecast at $20.72 and continuing higher through 2050 to an average of $201.01 and a max of $328.94, indicating substantial upside in the long run.
A major floor 10.7% below — a decisive break under it would weaken the trend.
The nearest floor, 4.3% below — buyers have tended to step in here.
The nearest ceiling, 3.7% above — a clean break opens room to run.
A major ceiling 7.8% above — clearing it would confirm fresh momentum.
Key SBRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $20.75 | Sell | $20.70 | Sell |
| MA 10 | $20.86 | Sell | $20.75 | Sell |
| MA 20 | $20.72 | Sell | $20.68 | Sell |
| MA 50 | $20.32 | Buy | $20.42 | Buy |
| MA 100 | $19.99 | Buy | $20.04 | Buy |
| MA 200 | $19.34 | Buy | $19.44 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.62 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -85.29 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -1.45 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 0.20 | Buy |
| Ultimate (7,14,28) | 44.13 | Neutral |
| Momentum (10) | -0.52 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 20.61 | Sell |
| ADX (14) | 12.37 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is BULLISH with near-term momentum reflected in a 50 RSI (RSI14).
The stock trades near the 50-day and 200-day averages, with SMA50 at $20.33 and SMA200 at $19.32. Support is at $19.57 and resistance at $21.20, framing a constructive near-term range.
The explicit 30-day range runs from a low of $19.45 to a high of $22.07, highlighting a modest upside ceiling against current price levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.26 | $20.45 | $27.20 | 0% | Neutral | |
| $19.93 | $24.40 | $31.26 | +19% | Neutral | |
| $20.43 | $25.46 | $33.47 | +24% | Bullish | |
| $23.63 | $29.90 | $40.12 | +46% | Bullish | |
| $26.72 | $34.26 | $46.80 | +68% | Bullish | |
| $31.23 | $40.53 | $56.22 | +98% | Bullish | |
| $36.35 | $47.70 | $67.10 | +133% | Bullish | |
| $37.22 | $49.35 | $70.31 | +141% | Bullish | |
| $39.83 | $53.33 | $76.88 | +161% | Bullish | |
| $43.15 | $58.33 | $85.01 | +185% | Bullish | |
| $64.54 | $90.97 | $138.90 | +345% | Bullish | |
| $132.66 | $200.50 | $328.07 | +880% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $18.26 | $20.45 | $23.94 | +0.00% |
| June 2026 | $17.39 | $20.28 | $24.12 | -0.83% |
| July 2026 | $17.30 | $20.30 | $24.37 | +0.10% |
| August 2026 | $17.75 | $20.92 | $25.30 | +3.07% |
| September 2026 | $17.90 | $21.17 | $25.75 | +1.18% |
| October 2026 | $17.73 | $21.05 | $25.74 | -0.57% |
| November 2026 | $18.04 | $21.47 | $26.38 | +2.01% |
| December 2026 | $18.46 | $22.04 | $27.20 | +2.62% |
Click any year to see its month-by-month SBRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SBRA price prediction for 2026 points to an average of $20.45 (low $18.26, high $27.20) — a potential gain of 0% on today's $20.45. A consolidation phase looks the most probable path here.
In 2027, SBRA is projected to trade between $19.93 and $31.26, averaging $24.40 — a potential gain of +19% from today's $20.45. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
Sabra Health Care REIT, Inc.'s 2028 outlook centres on $25.46, within a $20.43 to $33.47 range. That is up +4% on the projected 2027 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, SBRA could reach as high as $40.12, with a base case around $29.90 and support toward $23.63 — roughly +46% from $20.45. Momentum favours further upside here.
Expect SBRA to range from $26.72 to $46.80 through 2030. The $34.26 average target implies a +68% move from current prices. That is up +15% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The SBRA price prediction for 2031 points to an average of $40.53 (low $31.23, high $56.22) — a potential gain of +98% on today's $20.45. Momentum favours further upside here.
In 2032, SBRA is projected to trade between $36.35 and $67.10, averaging $47.70 — a potential gain of +133% from today's $20.45. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Sabra Health Care REIT, Inc.'s 2033 outlook centres on $49.35, within a $37.22 to $70.31 range. That is up +3% on the projected 2032 average. That marks a +141% change versus current levels. Momentum favours further upside here.
By 2034, SBRA could reach as high as $76.88, with a base case around $53.33 and support toward $39.83 — roughly +161% from $20.45. Buyers look set to stay in control over this stretch.
Expect SBRA to range from $43.15 to $85.01 through 2035. The $58.33 average target implies a +185% move from current prices. That is up +9% on the projected 2034 average. Momentum favours further upside here.
The SBRA price prediction for 2040 points to an average of $90.97 (low $64.54, high $138.90) — a potential gain of +345% on today's $20.45. Buyers look set to stay in control over this stretch.
In 2050, SBRA is projected to trade between $132.66 and $328.07, averaging $200.50 — a potential gain of +880% from today's $20.45. That is up +120% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SBRA today (≈ 48.899756 SBRA) could be worth
$9,804.36
+$8,804.36 (+880%) by 2050 · US Dollar
Based on the average projected SBRA price of $200.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBRAwould be worth at today's price.
$1,000 invested in SBRA on May 27, 2025 (≈ 56.818181 SBRA) would be worth
$1,161.93
+$161.93 (+16.2%) today · 1.16× · US Dollar
Based on a SBRA entry price of $17.6 vs. today's $20.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.06 | $971.04 | -2.9% |
| 1 month ago | $20.29 | $1,007.89 | +0.8% |
| 3 months ago | $20.86 | $980.35 | -2.0% |
| 6 months ago | $19.51 | $1,048.18 | +4.8% |
| 1 year ago | $17.6 | $1,161.93 | +16.2% |
| All time (5.0y) ago | $18.03 | $1,134.22 | +13.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBRA forecast.
Our base-case forecast reaches $41.00 around 2032.
Implied market cap at $41.00: $10.34B
The multi-year forecast shows a bullish bend from 2028 onward, following neutral signals in 2026 and 2027.
By 2030 the forecast averages $34.59 with a min of $26.98 and a max of $47.26, and a forecast ROI of 67 with sentiment BULLISH.
The trajectory continues higher, with 2040 averaging $91.84 and a ROI of 343.2, and 2050 averaging $201.01 with a ROI of 870.1 and sentiment BULLISH. These figures extend from 2028 onward, culminating in a strong long-term upside.
As with any forecast, these are estimates and not guarantees, and investor outcomes will depend on market dynamics and other risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $34.59, with a min of $26.98 and a max of $47.26. The forecasted ROI is 67 and sentiment is BULLISH.
The forecast turns BULLISH from 2028 onward, with an average price rising to $34.59 by 2030, $201.01 by 2050, and ROI values climbing to 343.2 by 2040 and 870.1 by 2050.
Yes. The max forecast reaches $140.24 by 2040 and $328.94 by 2050, indicating the possibility of exceeding $100 in the long term.
Current price is $20.72 and market cap is $5.23B.
Sentiment is BULLISH; RSI14 is 50. SMA50 is $20.33 and SMA200 is $19.32. Support is $19.57 and resistance is $21.20. The 30-day range is $19.45 to $22.07.
Sabra Health Care REIT, Inc. Community Discussion
0Share your Sabra Health Care REIT, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.